ProQR Therapeutics (PRQR) Return on Sales Growth (3y) (2016 - 2026)

ProQR Therapeutics (PRQR) Return on Sales Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - -
2 Nanobiotix 1,911.11 Bn 1,911.05 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 467.81 Bn 463.02 Bn 1.35 Bn 1.00
5 Vertex Pharmaceuticals 122.92 Bn 115.68 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 70.28 Bn 61.53 Bn 3.31 Bn 0.00
7 Belite Bio 62.88 Bn 62.88 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 0.00
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 1.00
10 ProQR Therapeutics 181.75 Mn 89.46 Mn - 7.00

Historic Data

Download Data
DateValue
Mar 31, 2026 7.00
Dec 31, 2025 17.00
Sep 30, 2025 25.00
Jun 30, 2025 11.00
Mar 31, 2025 10.00
Dec 31, 2024 74.00
Sep 30, 2024 15.00
Jun 30, 2024 64.00
Mar 31, 2024 -1.00
Dec 31, 2023 -1.00
Sep 30, 2023 -3.00
Jun 30, 2023 -5.00
Mar 31, 2023 -13.00
Dec 31, 2022 -18.00
Sep 30, 2022 -28.00
Jun 30, 2022 -13.00
Mar 31, 2022 -12.00
Dec 31, 2021 -75.00
Sep 30, 2021 -16.00
Jun 30, 2021 -63.00